Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Big bigCover of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

More books from Springer US

bigCover of the book Handbook of Atomization and Sprays by

bigCover of the book Chest Pain with Normal Coronary Angiograms: Pathogenesis, Diagnosis and Management by

bigCover of the book Valuation, Hedging and Speculation in Competitive Electricity Markets by

bigCover of the book Advances in Clinical Child Psychology by

bigCover of the book Social and Psychosocial Determinants of Self-Rated Health in Central and Eastern Europe by

bigCover of the book Ultra-High-Temperature Processing of Milk and Milk Products by

bigCover of the book The Pituitary Gland by

bigCover of the book Performance Evaluation and Benchmarking of Intelligent Systems by

bigCover of the book Biomedical Ethics and the Law by

bigCover of the book Broadband Infrastructure by

bigCover of the book Single-Channel Recording by

bigCover of the book History and Climate by

We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy